A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the ...

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Add Yahoo as a preferred source to see more of our stories on Google. Exercise really is as good as a drug, a groundbreaking new study found. In a global trial, workouts did better than pricey ...

June 3 -- MONDAY, June 2 (HealthDay News) -- Long-term smokers treated for advanced colon cancer are at increased risk for cancer recurrence, a Dana-Farber Cancer Institute study shows. Researchers ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...

A new clinical trial tested low-dose aspirin in patients with colon and rectal cancer, also referred to as colorectal cancer. The researchers wanted to see if taking aspirin daily could help prevent ...

Daily aspirin can cut in half the risk that colon cancer will come back Risk of recurrence was 55% lower in people who took 160 mg aspirin daily for three years Aspirin has several effects that might ...

A large Canadian study found that regular exercise after colon cancer treatment reduces the risk of cancer returning. Patients who followed a structured exercise program had higher survival rates than ...

In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...

Colorectal cancer led to 930,000 deaths and 1.9 million new cases globally in 2020. This number is projected to increase by 73% by 2040, resulting in approximately 1.6 million deaths per year, ...